Annual report 2019 for Initiator Pharma A/S ​​​​​​​

Initiator Pharma’s annual report for 2019 is now available on the company´s home page

http://initiatorpharma.com/investors/financial-reports/

For more information about Initiator Pharma, please contact:

Claus Elsborg Olesen, CEO
Telephone number: +45 6126 0035 

E-mail: ceo@initiatorpharma.com 

About Initiator Pharma

Initiator Pharma is a biotechnology company based in Aarhus, Denmark. The company’s main asset, IPED2015, is a candidate drug intended for patients with erectile dysfunction. The treatment is expected to improve the quality of life for a growing number of patients who are not responding to or cannot be treated with existing drugs on the market. Read more on www.initiatorpharma.com.